ANGELICA PATIENT ASSISTANCE PROGRA… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Phone

2123108378

Tax Period

2019-01-01 to 2019-12-31

ANGELICA PATIENT ASSISTANCE PROGRAM C/O DUVAL & STACHENFELD LLP, founded in 2005, is a small nonprofit in the Health Care sector that reported $233K in total revenue in fiscal year 2019. Revenue surged 131% from the prior year, signaling strong growth momentum. Expenses of $202K left a modest 13% surplus.

Mission

THE PURPOSE OF THIS ORGANIZATION IS TO ENHANCE THE LIVES OF ECONOMICALLY DISADVANTAGED PATIENTS IN NEED OF LONG-TERM MEDICAL CARE; TO SUPPORT LONG-TERM MEDICAL CARE FACILITIES, TO DO ANY OTHER ACT OR THING INCIDENTAL TO OR CONNECTED WITH THE FOREGOING PURPOSES OR IN ADVANCEMENT THEREOF.

Program Service Accomplishments

Program 1

Expenses: $195,791

VARIOUS ACTIVITES TO CARRY OUT THE EXEMPT PURPOSE OF THE ORGANIZATION SUCH AS, FIELD TRIPS, ARTS AND CRAFTS PROGRAMS, AND SEASONAL THEMED DANCES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2019)

Revenue Breakdown

Contributions & Grants $231,254

Program Service Revenue $0

Investment Income $2,231

Other Revenue $0

TOTAL REVENUE $233,485

Expense Breakdown

Grants Paid $60,000

Salaries & Benefits $0

Fundraising Expenses $2,231

Program Expenses $195,791

Other Expenses $142,023

TOTAL EXPENSES $202,023

Year-over-Year Comparison

	2019	2018	Change
Revenue	$233,485	$101,100	+1.3%
Expenses	$202,023	$138,309	+0.5%
Net Income	$31,462	$-37,209	-1.8%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ALEXIS BANASZAK MADDEN	BOARD MEMBER	2.00	Director	$0	$0	$0
ANDREW LUU	BOARD MEMBER	2.00	Director	$0	$0	$0
CARMEL NAPOLITANO	VICE PRESIDENT	4.00	Officer Director	$0	$0	$0
DENISE KAZMIER	BOARD MEMBER	4.00	Director	$0	$0	$0
GLORIA SWABY	BOARD MEMBER	2.00	Director	$0	$0	$0
GRACE SOTOMAYOR	BOARD MEMBER	2.00	Director	$0	$0	$0
JILL ALCOTT	BOARD MEMBER	4.00	Director	$0	$0	$0
KATHLEEN CAVANAUGH	TREASURER	4.00	Officer Director	$0	$0	$0
TRISHA DUVAL	PRESIDENT/EXECUTIVE DIRECT	25.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2019	$233,485	$202,023	$182,046	$31,462

ANGELICA PATIENT ASSISTANCE PROGRAM C/O DUVAL & STACHENFELD LLP